Quantum BioPharma Ltd. Key Management Personnel Compensation Share-based Payment
Quantum BioPharma Ltd. (QNTM) reported Key Management Personnel Compensation Share-based Payment of $1.99 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2026-03-26
CAD
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2019-12-31 | 12.48M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | 3.22M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Key Management Personnel Compensation Share-based Payment 3 month | Key Management Personnel Compensation Share-based Payment 6 month | Key Management Personnel Compensation Share-based Payment 9 month | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$191.83K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $678.08K derived: sum of 2 quarters · filed 2026-03-26 | $678.08K derived: sum of 3 quarters · filed 2026-03-26 | $1.99M 20-F · filed 2026-03-26 |
| 2025-09-30 | $869.91K 6-K · filed 2025-11-06 | $869.91K derived: sum of 2 quarters · filed 2025-11-06 | $2.19M 6-K · filed 2025-11-06 | $905.91K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $0.00 6-K · filed 2025-08-07 | $1.32M 6-K · filed 2025-08-07 | $36.01K derived: sum of 3 quarters · filed 2026-03-26 | $57.54K derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | $1.32M 6-K/A · filed 2025-06-16 | $36.01K derived: sum of 2 quarters · filed 2026-03-26 | $57.54K derived: sum of 3 quarters · filed 2026-03-26 | $57.54K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | -$1.28M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$1.26M derived: sum of 2 quarters · filed 2026-03-26 | -$1.26M derived: sum of 3 quarters · filed 2026-03-26 | $1.09M 20-F · filed 2026-03-26 |
| 2024-09-30 | $21.53K 6-K · filed 2025-11-06 | $21.53K derived: sum of 2 quarters · filed 2025-11-06 | $2.37M 6-K · filed 2025-11-06 | $38.28K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-06-30 | $0.00 6-K · filed 2025-08-07 | $0.00 6-K · filed 2025-08-07 | $16.75K derived: sum of 3 quarters · filed 2026-03-26 | $16.75K derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-03-31 | $0.00 6-K/A · filed 2025-06-16 | $16.75K derived: sum of 2 quarters · filed 2026-03-26 | $16.75K derived: sum of 3 quarters · filed 2026-03-26 | $303.58K derived: sum of 4 quarters · filed 2026-03-26 |
| 2023-12-31 | $16.75K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $16.75K derived: sum of 2 quarters · filed 2026-03-26 | $303.58K derived: sum of 3 quarters · filed 2026-03-26 | $1.98M 20-F · filed 2026-03-26 |
| 2023-09-30 | $0.00 6-K · filed 2024-11-12 | $286.83K derived: sum of 2 quarters · filed 2024-11-12 | $1.96M 6-K · filed 2024-11-12 | |
| 2023-06-30 | $286.83K 6-K/A · filed 2024-08-19 | $2.34M 6-K/A · filed 2024-08-19 | ||
| 2022-12-31 | $1.35M 20-F/A · filed 2025-03-31 | |||
| 2021-12-31 | $6.88M 20-F · filed 2024-04-02 | |||
| 2020-12-31 | $7.05M 20-F · filed 2023-03-31 | |||
| 2019-12-31 | $9.39M 20-F · filed 2022-03-31 |